GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
52.20
-2.82 (-5.13%)
Apr 28, 2026, 4:00 PM EDT - Market closed
GRAIL Revenue
In the year 2025, GRAIL had annual revenue of $147.17M with 17.18% growth. GRAIL had revenue of $43.60M in the quarter ending December 31, 2025, with 13.97% growth.
Revenue (ttm)
$147.17M
Revenue Growth
+17.18%
P/S Ratio
14.55
Revenue / Employee
$161,727
Employees
910
Market Cap
2.14B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qiagen | 2.09B |
| RadNet | 2.04B |
| Sotera Health Company | 1.16B |
| NeoGenomics | 727.33M |
| OPKO Health | 606.88M |
| Veracyte | 517.15M |
| GeneDx Holdings | 427.54M |
| Twist Bioscience | 391.56M |
GRAL News
- 6 days ago - GRAIL to Announce First Quarter 2026 Financial Results - PRNewsWire
- 7 days ago - GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting - PRNewsWire
- 20 days ago - Grail, Epic Plan Galleri Test Integration For 450 Health Systems - Benzinga
- 21 days ago - GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide - PRNewsWire
- 25 days ago - GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 27 days ago - Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection - PRNewsWire
- 6 weeks ago - Grail CEO Bob Ragusa to retire, Josh Ofman named successor - Reuters
- 6 weeks ago - GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor - PRNewsWire